Your browser doesn't support javascript.
loading
HER3 genomic gain and sensitivity to gefitinib in advanced non-small-cell lung cancer patients.
Cappuzzo, F; Toschi, L; Domenichini, I; Bartolini, S; Ceresoli, G L; Rossi, E; Ludovini, V; Cancellieri, A; Magrini, E; Bemis, L; Franklin, W A; Crino, L; Bunn, P A; Hirsch, F R; Varella-Garcia, M.
Affiliation
  • Cappuzzo F; Department of Medicine/Medical Oncology and Pathology, University of Colorado Cancer Center, Campus Box 8117; PO Box 6511, Aurora, CO 80045, USA.
Br J Cancer ; 93(12): 1334-40, 2005 Dec 12.
Article in En | MEDLINE | ID: mdl-16288303
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Carcinoma, Non-Small-Cell Lung / Receptor, ErbB-3 / Lung Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2005 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Carcinoma, Non-Small-Cell Lung / Receptor, ErbB-3 / Lung Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2005 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido